Search results for: 'screen compressor place'

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

Decarbonization in the commercial and industrial (C&I) sector is a critical component of the global energy transition, presenting both significant challenges and massive growth opportunities. It will entail the optimization and electrification of the energy demand while transitioning to low-carbon energy sources. The C&I sector is heterogeneous, wh...

19 Jan 2024  |  Europe  |  Market Research

European Non-invasive Prenatal Testing Market, Forecast to 2028

Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe

Infographics

×

The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products non-invasive nature compared to traditional...

27 Jun 2018  |  Global  |  Market Research

Vision 2025—Healthcare in the Smart Home

Opportunities Lie in the Integration of Big Data, AI, Aging-in-Place, Disease Management, and Wellness to Optimize a Single Consumer Health Platform

Infographics

×

Key Issues Addressed

Smart homes are no longer an emerging concept. Consumers are not only warming up to the idea but also buying home automation products. Smart speakers seem to be the favorite, with sales jumping from a meager 6 million units in 2016 to a whopping 33.2 million units in 2017. The developing ecosystem of home automation products that each of these curr...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...

13 Sep 2021  |  North America  |  Market Research

US Department of Homeland Security 2022 Budget Analysis and Growth Opportunities

Agencies Want Multipronged Protections in Place as a Devastating Pandemic, Social Unrest, and Political Discord Continue to Pose T

Infographics

×

Key Issues Addressed

The 2022 Department of Homeland Security (DHS) budget request released in May 2021 reveals an increase from the 2021 enacted budget. The new budget request reflects the Biden administration’s commitment to: • Coast Guard modernization • Confront disaster challenges • Improve federal cybersecurity across government • Improve transpor...

30 Nov 2017  |  Europe  |  Market Research

Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

Infographics

×

Key Issues Addressed

Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...

New and used vehicles can be purchased in a variety of ways in Europe, whether through franchised car dealerships, OEM online channels, or third-party online marketplaces. Automakers are exploring ways to reach out directly to customers to reduce retail operating costs while new car dealers want more effective ways to market and sell their inventor...

Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. Th...